Zealand Pharma’s drug for rare metabolic disease smashes phase III
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
After a year of slumping stock prices, Zealand Pharma is striking back, as its peptide…
Evotec and Sernova are set to join forces to advance a beta cell replacement therapy…
The UK company F2G Ltd. has announced a strategic collaboration with Japanese pharmaceutical company Shionogi…
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
The stock price of the French Covid-19 vaccine maker Valneva has been knocked down by…
Domain Therapeutics, a biopharmaceutical company in France and Canada developing cancer immunotherapies targeting G protein-coupled…
Private biotech investments in Europe were on a steady decline in April 2022 as biotech…
The French startup creator eureKARE has set up a special purposes acquisition company (SPAC) with…
Tapping into the increasingly sophisticated market for meat alternatives, the Swedish synthetic biology startup Melt&Marble…
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
The German firm Tubulis has raised a €60M Series B round to advance cancer drugs…
The Danish National Genome Center has teamed up with the UK firm Lifebit to improve…